Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-41

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) with gemcitabine, after cytoreductive surgery, may reduce the tumor progression of pancreatic cancer through the reduction of the neoplastic volume and the subpopulation of residual pancreatic cancer stem cells, improving the survival of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gastrointest Oncol
Autori principali: Padilla-Valverde, David, García-Santos, Esther, Sanchez, Susana, Manzanares, Carmen, Rodriguez, Marta, González, Lucia, Ambrós, Alfonso, Cano, Juana M., Serrano, Leticia, Bodoque, Raquel, Vergara, Teresa, Martin, Jesus
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2021
Soggetti:
Original Article on Pancreas Cancer
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100727/
https://ncbi.nlm.nih.gov/pubmed/33968428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-238
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi